NYSE - Delayed Quote • USD
Integer Holdings Corporation (ITGR)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 7 |
| Avg. Estimate | 1.25 | 1.39 | 5.3 | 6.05 |
| Low Estimate | 1.14 | 1.35 | 5.25 | 5.94 |
| High Estimate | 1.31 | 1.43 | 5.37 | 6.16 |
| Year Ago EPS | 1.14 | 1.27 | 4.67 | 5.3 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 6 |
| Avg. Estimate | 437.78M | 447.13M | 1.76B | 1.88B |
| Low Estimate | 422.5M | 440.3M | 1.75B | 1.86B |
| High Estimate | 443.1M | 451.33M | 1.77B | 1.91B |
| Year Ago Sales | -- | 376.71M | 1.6B | 1.76B |
| Sales Growth (year/est) | -- | 18.70% | 10.10% | 7.00% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1 | 1.1 | 1.33 | 1.11 |
| EPS Actual | 1.14 | 1.27 | 1.39 | 1.14 |
| Difference | 0.14 | 0.17 | 0.06 | 0.03 |
| Surprise % | 14.00% | 15.50% | 4.50% | 2.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.25 | 1.39 | 5.3 | 6.05 |
| 7 Days Ago | 1.26 | 1.41 | 5.31 | 6.04 |
| 30 Days Ago | 1.25 | 1.41 | 5.3 | 6.02 |
| 60 Days Ago | 1.25 | 1.41 | 5.31 | 6.03 |
| 90 Days Ago | 1.37 | 1.42 | 5.41 | 6.17 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 2 |
| Up Last 30 Days | 1 | -- | 1 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 3 | 3 | 2 | 2 |
Growth Estimates
| CURRENCY IN USD | ITGR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 9.60% | -- | -- | 6.50% |
| Next Qtr. | 9.40% | -- | -- | 12.00% |
| Current Year | 13.50% | -- | -- | 5.30% |
| Next Year | 14.20% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 13.60% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 3.65% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Benchmark: Buy to Buy | 4/26/2024 |
| Upgrade | B of A Securities: Neutral to Buy | 4/15/2024 |
| Maintains | Keybanc: Overweight to Overweight | 4/9/2024 |
| Maintains | Benchmark: Buy to Buy | 3/28/2024 |
| Initiated | CL King: Buy | 3/14/2024 |
| Maintains | Keybanc: Overweight to Overweight | 2/16/2024 |
Related Tickers
CNMD CONMED Corporation
65.78
+6.27%
IART Integra LifeSciences Holdings Corporation
28.34
-0.25%
PEN Penumbra, Inc.
204.41
-0.53%
EW Edwards Lifesciences Corporation
86.43
-1.80%
PODD Insulet Corporation
166.19
+1.23%
NVRO Nevro Corp.
11.32
-2.58%
GKOS Glaukos Corporation
99.48
-0.63%
LIVN LivaNova PLC
55.53
+0.78%
IRTC iRhythm Technologies, Inc.
111.91
+0.58%
UFPT UFP Technologies, Inc.
213.25
+1.72%